How the pediatric RSV shot shortage is hitting Austin

TEXAS (KXAN) — In July, the U.S. Food and Drug Administration announced approval of a new drug aimed at preventing respiratory syncytial virus (RSV) in infants and young children two years and younger. Now, shortages in shot supply levels are leaving many families without access to the drug, as respiratory illnesses spread in the greater Austin region ahead of the colder winter season."I think nationally and even locally, the demand for the RSV [shot] was a lot larger than the manufacturer